A new treatment has been approved to treat relapsing forms of multiple sclerosis (MS) in adults. The oral treatment, Mavenclad, is approved for treating relapsing-remitting forms of the illness as well as active secondary progressive disease. The federal Food and Drug Administration (FDA), which approved Mavenclad, said that it is not recommended for MS patients… Continue reading New Treatment for MS Approved